ZA891769B - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ZA891769B
ZA891769B ZA891769A ZA891769A ZA891769B ZA 891769 B ZA891769 B ZA 891769B ZA 891769 A ZA891769 A ZA 891769A ZA 891769 A ZA891769 A ZA 891769A ZA 891769 B ZA891769 B ZA 891769B
Authority
ZA
South Africa
Prior art keywords
well
novel compounds
heterocyclic compounds
acetylcholine
alzheimer
Prior art date
Application number
ZA891769A
Other languages
English (en)
Inventor
Povl Krogsgaard-Larsen
Erik Falch
Henrik Pedersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888806013A external-priority patent/GB8806013D0/en
Priority claimed from GB888822564A external-priority patent/GB8822564D0/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of ZA891769B publication Critical patent/ZA891769B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
ZA891769A 1988-03-14 1989-03-08 Heterocyclic compounds ZA891769B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888806013A GB8806013D0 (en) 1988-03-14 1988-03-14 Heterocyclic compounds
GB888822564A GB8822564D0 (en) 1988-09-26 1988-09-26 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ZA891769B true ZA891769B (en) 1989-12-27

Family

ID=26293631

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891769A ZA891769B (en) 1988-03-14 1989-03-08 Heterocyclic compounds

Country Status (17)

Country Link
US (1) US4923880A (fr)
EP (1) EP0336555B1 (fr)
JP (1) JPH01275585A (fr)
AT (1) ATE81130T1 (fr)
AU (1) AU630085B2 (fr)
CA (1) CA1337201C (fr)
DE (1) DE68903019T2 (fr)
DK (1) DK169676B1 (fr)
ES (1) ES2052901T3 (fr)
FI (1) FI91411C (fr)
GR (1) GR3006606T3 (fr)
IE (1) IE62782B1 (fr)
IL (1) IL89351A0 (fr)
NO (1) NO177145C (fr)
NZ (1) NZ228182A (fr)
PT (1) PT89992B (fr)
ZA (1) ZA891769B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645862B1 (fr) * 1989-04-18 1991-07-12 Esteve Labor Dr Derives d'isothiazolo-pyrydone azetidinyl substitues, leur preparation et leur application en tant que medicaments
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
WO1997020561A1 (fr) * 1995-12-07 1997-06-12 Eli Lilly And Company Composition servant a traiter la douleur
US20050137222A1 (en) * 2003-12-18 2005-06-23 H. Lundbeck A/S Treatment of insomnia in human patients
US20110098777A1 (en) * 2009-10-23 2011-04-28 Silverstone Leon M Method and apparatus for treatment of neurodegenerative diseases including depression, mild cognitive impairment, and dementia
LT3274331T (lt) 2015-03-24 2020-04-10 H. Lundbeck A/S 4,5,6,7-tetrahidroizozaksolo[5,4-c]piridin-3-olio gamybos būdas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8314391D0 (en) * 1983-05-24 1983-06-29 Kefalas As Heterocyclic compounds
IL87709A (en) * 1987-09-16 1992-11-15 Pfizer Process for preparing haloalkyl thiazoles and some such novel haloalkyl thiazoles
DE3820775A1 (de) * 1988-06-20 1989-12-21 Thomae Gmbh Dr K Neue 4,5,7,8-tetrahydro-6h-thiazolo(5,4,-d)azepine, ihre herstellung und ihre verwendung als arzneimittel
JP3054738B2 (ja) * 1988-07-22 2000-06-19 武田薬品工業株式会社 チアゾロ[5,4―b]アゼピン誘導体

Also Published As

Publication number Publication date
JPH01275585A (ja) 1989-11-06
AU630085B2 (en) 1992-10-22
ES2052901T3 (es) 1994-07-16
GR3006606T3 (fr) 1993-06-30
NO891071L (no) 1989-09-15
NO177145C (no) 1995-07-26
FI891155A (fi) 1989-09-15
PT89992B (pt) 1994-05-31
FI91411B (fi) 1994-03-15
NZ228182A (en) 1990-08-28
DK121789D0 (da) 1989-03-14
CA1337201C (fr) 1995-10-03
DE68903019D1 (de) 1992-11-05
DK121789A (da) 1989-09-15
FI891155A0 (fi) 1989-03-10
EP0336555A1 (fr) 1989-10-11
DE68903019T2 (de) 1993-07-08
AU3126289A (en) 1989-09-14
IE890648L (en) 1989-09-14
DK169676B1 (da) 1995-01-09
NO177145B (no) 1995-04-18
IE62782B1 (en) 1995-02-22
IL89351A0 (en) 1989-09-10
US4923880A (en) 1990-05-08
PT89992A (pt) 1989-11-10
FI91411C (fi) 1994-06-27
NO891071D0 (no) 1989-03-13
ATE81130T1 (de) 1992-10-15
EP0336555B1 (fr) 1992-09-30

Similar Documents

Publication Publication Date Title
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
IL99165A0 (en) Heterocyclic compounds and their preparation and pharmaceutical compositions containing them
IL93817A0 (en) N-(3-hydroxy-4-piperidinyl)-(dihydrobenzofuran,dihydro-2h-benzopyran or dihydro-benzodioxin)carboxamide derivatives,their preparation and pharmaceutical compositions containing them
DE69019111T2 (de) Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion.
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
ZA904893B (en) Iibeta-aryl-4-estrenes,process for their production as well as their use as pharmaceutical agents
IL87765A0 (en) L-dopa derivatives and their acid addition salts,process for producing same and pharmaceutical compositions containing them
AU649882B2 (en) Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
DE69501359T2 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
ZA891769B (en) Heterocyclic compounds
NZ232207A (en) Dihydrobenz(c)acridine derivatives and pharmaceutical compositions
NZ231293A (en) 1,2,3,4-tetrahydro-1,9-acridinediamines, homologues thereof, and pharmaceutical compositions
IT1223395B (it) Composti ad attivita' cardiovascolare
DE69013983D1 (de) 4,5,6,11-Tetrahydrobenzo[6,7]-cycloocta[1,2-b]thiophen-6,11-imine und 6,11-Dihydrobenzo[6,7]-cycloocta[1,2-b]thiophen-6,11-imine.
HUT51622A (en) Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance
IT1248525B (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.